Lycopene Consumption and Risk of Colorectal Cancer: A Meta-Analysis of Observational Studies

Nutrition and Cancer

Volumn 68, Issue 7, 2016, Pages 1083-1096

  Wang, Xin ^a   Yang, Hui Hui ^b   Liu, Yan ^c   Zhou, Quan ^d   Chen, Zi Hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c Second Artillery General Hospital   (China)

^d First People's Hospital of Changde City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAROTENOID;

ARTICLE; CANCER RISK; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; DISEASE ASSOCIATION; DOSE RESPONSE; FOOD INTAKE; HUMAN; OBSERVATIONAL STUDY; QUALITY CONTROL; SENSITIVITY ANALYSIS; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL TUMOR; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; HEALTHY DIET; META ANALYSIS; REPRODUCIBILITY; RISK;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HEALTHY DIET; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK;

EID: 84980010011     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1206579     Document Type: Article

References (96)

1. K.Smolinska and P.Paluszkiewicz:Risk of colorectal cancer in relation to frequency and total amount of red meat consumption. Systematic review and meta-analysis. Arch Med Sci 6(4), 605–610, 2010.
2. A.Geelen, J.M.Schouten, C.Kamphuis, B.E.Stam, J.Burema, et al.:Fish consumption, n-3 fatty acids, and colorectal cancer:a meta-analysis of prospective cohort studies. Am J Epidemiol 166(10), 1116–1125, 2007.
3. A.Jemal, T.Murray, E.Ward, A.Samuels, R.C.Tiwari, et al.:Cancer statistics, 2005. CA Cancer J Clin 55(1), 10–30, 2005.
4. M.Tuzcu, A.Aslan, Z.Tuzcu, M.Yabas, I.H.Bahcecioglu, et al.:Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-kappaB and regulating Nrf2/HO-1 pathway. Mol Nutr Food Res 56(9), 1477–1481, 2012.
5. E.Cho, S.A.Smith-Warner, D.Spiegelman, W.L.Beeson, P.A.van den Brandt, et al.:Dairy foods, calcium, and colorectal cancer:a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96(13), 1015–1022, 2004.
6. T.Norat and E.Riboli:Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 57(1), 1–17, 2003.
7. K.W.Kinzler and B.Vogelstein:Lessons from hereditary colorectal cancer. Cell 87(2), 159–170, 1996.
8. M.L.Slattery, J.Benson, K.Curtin, K.N.Ma, D.Schaeffer, and J.D.Potter:Carotenoids and colon cancer. Am J Clin Nutr 71(2), 575–582, 2000.
9. E.Giovannucci, M.J.Stampfer, G.Colditz, E.B.Rimm, and W.C.Willett:Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 84(2), 91–98, 1992.
10. T.M.de Kok, P.de Waard, L.C.Wilms, and S.G.van Breda:Antioxidative and antigenotoxic properties of vegetables and dietary phytochemicals:the value of genomics biomarkers in molecular epidemiology. Mol Nutr Food Res 54(2), 208–217, 2010.
11. B.Bao, A.S.Azmi, S.Ali, A.Ahmad, Y.Li, et al.:The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta 1826(2), 272–296, 2012.
12. F.H.Sarkar, Y.Li, Z.Wang, and D.Kong:The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev 29(3), 383–394, 2010.
13. H.L.Tan, J.M.Thomas-Ahner, E.M.Grainger, L.Wan, D.M.Francis, et al.:Tomato-based food products for prostate cancer prevention:what have we learned? Cancer Metastasis Rev 29(3), 553–568, 2010.
14. S.Agarwal and A.V.Rao:Tomato lycopene and its role in human health and chronic diseases. CMAJ Canadian Med Assoc J 163(6), 739–744, 2000.
15. M.C.Dias, N.F.Vieiralves, M.I.Gomes, D.M.Salvadori, M.A.Rodrigues, and L.F.Barbisan:Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis. Food Chem Toxicol 48(3), 772–780, 2010.
16. International symposium on the role of tomato products and carotenoids in disease prevention. April 10, 2001:Proceedings and abstracts. Exp Biol Med (Maywood) 227(10), 843–937, 2002.
17. P.Palozza, M.Colangelo, R.Simone, A.Catalano, A.Boninsegna, et al.:Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 31(10), 1813–1821, 2010.
18. E.Giovannucci, E.B.Rimm, Y.Liu, M.J.Stampfer, and W.C.Willett:A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94(5), 391–398, 2002.
19. A.V.Rao, M.R.Ray, and L.G.Rao:Lycopene. Adv Food Nutr Res 51, 99–164, 2006.
20. F.H.Sarkar, Y.Li, Z.Wang, and D.Kong:Cellular signaling perturbation by natural products. Cell Signal 21(11), 1541–1547, 2009.
21. E.Giovannucci:Tomatoes, tomato-based products, lycopene, and cancer:Review of the epidemiologic literature. J Natl Cancer Inst 91(4), 317–331, 1999.
22. C.Liu and R.M.Russell:Nutrition and gastric cancer risk:an update. Nutr Rev 66(5), 237–249, 2008.
23. C.J.Kavanaugh, P.R.Trumbo, and K.C.Ellwood:The U.S. Food and Drug Administration's evidence-based review for qualified health claims:tomatoes, lycopene, and cancer. J Natl Cancer Inst 99(14), 1074–1085, 2007.
24. S.Mannisto, S.S.Yaun, D.J.Hunter, D.Spiegelman, H.O.Adami, et al.:Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol 165(3), 246–255, 2007.
25. C.La Vecchia:Tomatoes, lycopene intake, and digestive tract and female hormone-related neoplasms. Exp Biol Med (Maywood, NJ) 227(10), 860–863, 2002.
26. G.Kune and L.Watson:Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer 56(1), 11–21, 2006.
27. P.Terry, M.Jain, A.B.Miller, G.R.Howe, and T.E.Rohan:Dietary carotenoid intake and colorectal cancer risk. Nutr Cancer 42(2), 167–172, 2002.
28. N.Malila, J.Virtamo, M.Virtanen, P.Pietinen, D.Albanes, and L.Teppo:Dietary and serum (alpha)-tocopherol, (beta)-carotene and retinol, and risk for colorectal cancer in male smokers. Eur J Clin Nutr 56(7), 615–621, 2002.
29. M.S.Lu, Y.J.Fang, Y.M.Chen, W.P.Luo, Z.Z.Pan, et al.:Higher intake of carotenoid is associated with a lower risk of colorectal cancer in Chinese adults:a case-control study. Eur J Nutr 54(4), 619–628, 2014.
30. G.Kune and L.Watson:Lowering the risk of rectal cancer among habitual beer drinkers by dietary means. Adv Preventive Med 874048, 2011.
31. M.L.Slattery, R.K.Wolff, J.Herrick, B.J.Caan, and W.Samowitz:Tumor markers and rectal cancer:Support for an inflammation-related pathway. Int J Cancer 125(7), 1698–1704, 2009.
32. Y.Chaiter, S.B.Gruber, A.Ben-Amotz, R.Almog, H.S.Rennert, et al.:Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes Control CCC 20(8), 1327–1338, 2009.
33. K.Musa-Veloso, J.W.Card, A.W.Wong, and D.A.Cooper:Influence of observational study design on the interpretation of cancer risk reduction by carotenoids. Nutr Rev 67(9), 527–545, 2009.
34. D.F.Stroup, J.A.Berlin, S.C.Morton, et al.:Meta-analysis of observational studies in epidemiology:a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15), 2008–2012, 2000.
35. A.Stang:Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9), 603–605, 2010.
36. D.Atkins, D.Best, P.A.Briss, M.Eccles, Y.Falck-Ytter, et al.:Grading quality of evidence and strength of recommendations. BMJ 328(7454), 1490, 2004.
37. S.Greenland:Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9, 1–30, 1987.
38. S.Greenland and M.P.Longnecker:Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11), 1301–1309, 1992.
39. N.Orsini, R.Bellocco, and S.Greenland:Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1), 40, 2006.
40. R.DerSimonian and N.Laird:Meta-analysis in clinical trials. Control Clin Trials 7(3), 177188, 1986.
41. J.P.Higgins, S.G.Thompson, J.J.Deeks, and D.G.Altman:Measuring inconsistency in meta-analyses. BMJ 327(7414), 557–560, 2003.
42. R.J.Hardy and S.G.Thompson:Detecting and describing heterogeneity in meta-analysis. Stat Med 17(8), 841–856, 1998.
43. J.L.Peters, A.J.Sutton, D.R.Jones, K.R.Abrams, and L.Rushton:Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10), 991–996, 2008.
44. C.B.Begg and M.Mazumdar:Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4), 1088–1101, 1994.
45. M.Egger, G.Davey Smith, M.Schneider, and C.Minder:Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109), 629–634, 1997.
46. J.G.Zhou, X.Tian, X.Wang, J.H.Tian, Y.Wang, et al.:Treatment on advanced NSCLC:platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials. Med Oncol 32(2), 471, 2015.
47. S.M.Enger, M.P.Longnecker, M.J.Chen, J.M.Harper, E.R.Lee, et al.:Dietary intake of specific carotenoids and vitamins A, C, and E, and prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 5(3), 147–153, 1996.
48. M.A.Murtaugh, K.N.Ma, J.Benson, K.Curtin, B.Caan, and M.L.Slattery:Antioxidants, carotenoids, and risk of rectal cancer. Am J Epidemiol 159(1), 32–41, 2004.
49. A.Nkondjock and P.Ghadirian:Dietary carotenoids and risk of colon cancer:Case-control study. Int J Cancer 110(1), 110–116, 2004.
50. A.Ramadas and M.Kandiah:Nutritional status and the risk for colorectal adenomas:A case-control study in Hospital Kuala Lumpur, Malaysia. Pakistan J Nutr 9(3), 269–278, 2010.
51. S.Y.Park, A.M.Nomura, S.P.Murphy, L.R.Wilkens, B.E.Henderson, and L.N.Kolonel:Carotenoid intake and colorectal cancer risk:The Multiethnic Cohort study. J Epidemiol 19(2), 63–71, 2009.
52. S.Jung, K.Wu, E.Giovannucci, D.Spiegelman, W.C.Willett, and S.A.Smith-Warner:Carotenoid intake and risk of colorectal adenomas in a cohort of male health professionals. Cancer Causes Control 24(4), 705–717, 2013.
53. A.Leslie, F.A.Carey, N.R.Pratt, and R.J.Steele:The colorectal adenoma-carcinoma sequence. Br J Surg 89(7), 845–860, 2002.
54. M.S.Lu, Y.J.Fang, Y.M.Chen, W.P.Luo, Z.Z.Pan, et al.:Higher intake of carotenoid is associated with a lower risk of colorectal cancer in Chinese adults:a case-control study. Eur J Nutr 54(4), 619–628, 2014.
55. Y.Chaiter, S.B.Gruber, A.Ben-Amotz, R.Almog, H.S.Rennert, et al.:Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes Control 20(8), 1327–1338, 2009.
56. N.E.Moran, J.W.Erdman, and S.K.Clinton:Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution. Arch Biochem Biophys 539(2), 171–180, 2013.
57. E.Cho, S.A.Smith-Warner, J.Ritz, P.A.van den Brandt, G.A.Colditz, et al.:Alcohol intake and colorectal cancer:a pooled analysis of 8 cohort studies. Ann Intern Med 140(8), 603–613, 2004.
58. J.A.Olson and N.I.Krinsky:Introduction:the colorful, fascinating world of the carotenoids:important physiologic modulators. FASEB J 9(15), 1547–1550, 1995.
59. R.B.van Breemen and N.Pajkovic:Multitargeted therapy of cancer by lycopene. Cancer Lett 269(2), 339–351, 2008.
60. H.Sies and W.Stahl:Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62(6 Suppl), 1315S–1321S, 1995.
61. M.Karas, H.Amir, D.Fishman, M.Danilenko, S.Segal, et al.:Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36(1), 101–111, 2000.
62. P.Kanagaraj, M.R.Vijayababu, B.Ravisankar, J.Anbalagan, M.M.Aruldhas, and J.Arunakaran:Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells. J Cancer Res Clin Oncol 133(6), 351–359, 2007.
63. J.Ma, E.Giovannucci, M.Pollak, and M.Stampfer:RESPONSE:Re:Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91(23), 2052, 1999.
64. S.Walfisch, Y.Walfisch, E.Kirilov, N.Linde, H.Mnitentag, et al.:Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients. Eur J Cancer Prev 16(4), 298–303, 2007.
65. A.Vrieling, D.W.Voskuil, J.M.Bonfrer, et al.:Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. Am J Clin Nutr 86(5), 1456–1462, 2007.
66. A.Walther, E.Johnstone, C.Swanton, R.Midgley, I.Tomlinson, and D.Kerr:Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9(7), 489–499.
67. T.Winder and H.J.Lenz:Molecular predictive and prognostic markers in colon cancer. Cancer Treat Rev 36(7), 550–556, 2010.
68. A.Bommareddy, W.Eggleston, S.Prelewicz, A.Antal, Z.Witczak, et al.:Chemoprevention of prostate cancer by major dietary phytochemicals. Anticancer Res 33(10), 4163–4174, 2013.
69. F.Y.Tang, H.J.Cho, M.H.Pai, and Y.H.Chen:Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem 20(6), 426–434, 2009.
70. E.Gouranton, C.Thabuis, C.Riollet, C.Malezet-Desmoulins, C.El Yazidi, et al.:Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22(7), 642–648, 2011.
71. D.Feng, W.H.Ling, and R.D.Duan:Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflam Res 59(2), 115–121, 2010.
72. K.Tominaga, K.Higuchi, E.Sasaki, R.Suto, T.Watanabe, et al.:Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells. Aliment Pharmacol Therap 20(Suppl 1), 143–150, 2004.
73. R.A.Soslow, A.J.Dannenberg, D.Rush, B.M.Woerner, K.N.Khan, et al.:COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89(12), 2637–2645, 2000.
74. M.Conacci-Sorrell, I.Simcha, T.Ben-Yedidia, J.Blechman, P.Savagner, and A.Ben-Ze'ev:Autoregulation of E-cadherin expression by cadherin-cadherin interactions:the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163(4), 847–857, 2003.
75. F.Y.Tang, M.H.Pai, and X.D.Wang:Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J Agric Food Chem 59(16), 9011–9021, 2011.
76. Y.Ogata, K.Miura, A.Ohkita, H.Nagase, and K.Shirouzu:Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma. The Kurume Med J 48(3), 211–218, 2001.
77. E.S.Hwang and H.J.Lee:Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp Biol Med (Maywood, NJ) 231(3), 322–327, 2006.
78. M.C.Lin, F.Y.Wang, Y.H.Kuo, and F.Y.Tang:Cancer chemopreventive effects of lycopene:suppression of MMP-7 expression and cell invasion in human colon cancer cells. J Agric Food Chem 59(20), 11304–11318, 2011.
79. Y.O.Park, E.S.Hwang, and T.W.Moon:The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. BioFactors (Oxford, England) 23(3), 129–139, 2005.
80. A.Nahum, L.Zeller, M.Danilenko, O.W.Prall, C.K.Watts, et al.:Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr 45(5), 275–282, 2006.
81. N.I.Ivanov, S.P.Cowell, P.Brown, P.S.Rennie, E.S.Guns, and M.E.Cox:Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr (Edinburgh, Scotland) 26(2), 252–263, 2007.
82. P.Palozza, S.Serini, A.Boninsegna, D.Bellovino, M.Lucarini, et al.:The growth-inhibitory effects of tomatoes digested in vitro in colon adenocarcinoma cells occur through down regulation of cyclin D1, Bcl-2 and Bcl-xL. Br J Nutr 98(4), 789–795, 2007.
83. A.L.Ferreira, K.J.Yeum, C.Liu, D.Smith, N.I.Krinsky, et al.:Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. J Nutr 130(5), 1256–1260, 2000.
84. R.S.Parker:Carotenoids in human blood and tissues. J Nutr 119(1), 101–104, 1989.
85. A.Muhlhofer, B.Buhler-Ritter, J.Frank, W.G.Zoller, P.Merkle, et al.:Carotenoids are decreased in biopsies from colorectal adenomas. Clin Nutr 22(1), 65–70, 2003.
86. C.Gartner, W.Stahl, and H.Sies:Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 66(1), 116–122, 1997.
87. W.Stahl and H.Sies:Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122(11), 2161–2166, 1992.
88. T.W.Boileau, A.C.Boileau, and J.W.ErdmanJr.:Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med 227(10), 914–949, 2002.
89. A.C.Boileau, N.R.Merchen, K.Wasson, C.A.Atkinson, and J.W.ErdmanJr.:Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr 129(6), 1176–1181, 1999.
90. A.Agarwal, H.Shen, S.Agarwal, and A.V.Rao:Lycopene content of tomato products:its stability, bioavailability and in vivo antioxidant properties. J Med Food 4(1), 9–15, 2001.
91. C.D.Davis, C.A.Swanson, R.G.Ziegler, B.Clevidence, J.T.Dwyer, et al.:Promises and perils of lycopene/tomato supplementation and cancer prevention:Executive summary report. J Nutr 135(8), 2014S–2029S, 2005.
92. S.Agarwal and A.V.Rao:Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 163(6), 739–744, 2000.
93. A.R.Mangels, J.M.Holden, G.R.Beecher, M.R.Forman, and E.Lanza:Carotenoid content of fruits and vegetables:an evaluation of analytic data. J Am Diet Assoc 93(3), 284–296, 1993.
94. V.Bohm, K.Frohlich, and R.Bitsch:Rosehip—a “new” source of lycopene? Mol Aspects Med 24(6), 385–389, 2003.
95. P.Palozza, D.Bellovino, R.Simone, A.Boninsegna, F.Cellini, et al.:Effect of (beta)-carotene-rich tomato lycopene (beta)-cyclase (tlcy-b) on cell growth inhibition in HT-29 colon adenocarcinoma cells. Br J Nutr 102(2), 207–214, 2009.
96. K.Canene-Adams, J.K.Campbell, S.Zaripheh, E.H.Jeffery, and J.W.ErdmanJr.:The tomato as a functional food. J Nutr 135(5), 1226–1230, 2005.